Citadel Advisors »

Astria Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 165k 7.68
2023-09-30 $229k 31k 7.46
2023-06-30 $104k 12k 8.33
2023-03-31 $332k 25k 13.30
2022-12-31 $2.4M 159k 14.89
2022-06-30 $893k 298k 3.00
2022-03-31 $2.9M 433k 6.71
2021-12-31 $2.6M 474k 5.39
2021-09-30 $2.7M 311k 8.84